Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biktarvy-Brigham and Women's Hospital
- Development stage
- Unknown
- Lead developer
- Gilead Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Biktarvy-Brigham and Women's Hospital refers to a specialized formulation of the FDA-approved HIV-1 medication Biktarvy (a fixed-dose combination of bictegravir, emtricitabine, and tenofovir alafenamide) modified with TruTag Technologies' silica microparticle taggants. Developed by Brigham and Women's Hospital, this system is designed to monitor medication adherence in people living with HIV. The silica microparticles are incorporated into the tablet coating and can be scanned using a smartphone camera and a companion app to record adherence events. The underlying medication, Biktarvy, functions by inhibiting HIV-1 replication through the combined action of an integrase strand transfer inhibitor (bictegravir) and two nucleoside reverse transcriptase inhibitors (emtricitabine and tenofovir alafenamide).
- Brand names
- Biktarvy
- Other names
- TruTag-coated BiktarvyTruTag silica microparticle tagged BiktarvyTruTag System
02
Targets
Human immunodeficiency virus type 1 reverse transcriptaseIntegrase allosteric pocket (HIV)
Beyond the preview
Go deeper on Biktarvy-Brigham and Women's Hospital.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biktarvy-Brigham and Women's Hospital.